KYTX
Financials
- Market Capitalization 517.63 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2885 |  CABA Cabaletta Bio, Inc. - Common Stock | 3.12 USD | -7.69% | +0.97% | +17.74% | +112.24% | 528.98 M USD | ||
| 2892 |  ENTX Entera Bio Ltd. - Ordinary Shares | 3.03 USD | -1.62% | -7.62% | -0.98% | +56.19% | 524.62 M USD | ||
| 2937 |  EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -4.24% | +0.64% | +21.54% | +25.40% | 485.31 M USD | ||
| 2943 |  EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.36% | +20.95% | -23.67% | 479.78 M USD |
Frequently asked questions about Kyverna Therapeutics, Inc. Common Stock
What is the Kyverna Therapeutics, Inc. Common Stock stock price today?
The current price of Kyverna Therapeutics, Inc. Common Stock (KYTX) is 8.37. Over the past 24 hours, the stock has changed by -3.13%. Follow the KYTX chart for real-time price dynamics.
What is the stock ticker of Kyverna Therapeutics, Inc. Common Stock?
Kyverna Therapeutics, Inc. Common Stock trades under the ticker KYTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kyverna Therapeutics, Inc. Common Stock stock going up?
KYTX has changed by +0.60% over the last week, +15.61% over the last month, and +133.15% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kyverna Therapeutics, Inc. Common Stock?
Kyverna Therapeutics, Inc. Common Stock currently has a market capitalization of 517.63 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kyverna Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Kyverna Therapeutics, Inc. Common Stock reported earnings of -0.63 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kyverna Therapeutics, Inc. Common Stock net income for the last quarter?
Kyverna Therapeutics, Inc. Common Stock reported net income of -38.32 M for the last quarter. The previous quarter showed -39.73 M, which means net income changed by +3.55%.
How many employees does Kyverna Therapeutics, Inc. Common Stock have?
As of the latest available data, Kyverna Therapeutics, Inc. Common Stock has 149 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Kyverna Therapeutics, Inc. Common Stock stock?
You can buy Kyverna Therapeutics, Inc. Common Stock (KYTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kyverna Therapeutics, Inc. Common Stock stock?
Investing in Kyverna Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYTX chart and related analysis on metatrader.com as part of your research.